# Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities

> **NCT05359419** · PHASE4 · UNKNOWN · sponsor: **Goldman, Butterwick, Fitzpatrick and Groff** · enrollment: 20 (estimated)

## Conditions studied

- Skin Neoplasms

## Interventions

- **COMBINATION_PRODUCT:** aminolevulinic acid hydrochloride gel, 10%
- **COMBINATION_PRODUCT:** aminolevulinic acid HCl topical solution, 20%

## Key facts

- **NCT ID:** NCT05359419
- **Lead sponsor:** Goldman, Butterwick, Fitzpatrick and Groff
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-15
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05359419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05359419, "Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05359419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*